What are the major opportunities in the Hyqvia market? What are the strategies for the Hyqvia market?

For detailed insights on the major opportunities and strategies in the Hyqvia market, Read More

How does the Hyqvia market relate to the overall economy and other similar markets?

For detailed insights on Hyqvia's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Hyqvia industry?

For detailed insights on the mergers and acquisitions in the Hyqvia industry, Read More

What are the key dynamics influencing the Hyqvia market growth? SWOT analysis of the Hyqvia market.

For detailed insights on the key dynamics influencing the Hyqvia market growth and SWOT analysis of the Hyqvia industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Hyqvia Global Market Report 2025

Name: Hyqvia Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Patient Demographics (Pediatric Patients, Adult Patients), By Distribution Channel (Hospitals, Specialty Pharmacies, Home Healthcare Providers, Retail Pharmacies), By Application (Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Other Applications)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Hyqvia Market?

Hyqvia is a combination therapy for primary immunodeficiency (PI) in adults and children, consisting of human immune globulin (IgG) to provide essential antibodies and recombinant human hyaluronidase (rHuPH20) to enhance absorption under the skin. Administered subcutaneously once every three to four weeks, it allows for larger, less frequent infusions at a single site, improving patient convenience compared to traditional therapies. Hyqvia helps reduce infection risk in individuals with low IgG levels due to PI, with common side effects including injection site reactions, headache, and flu-like symptoms.

The main types of hyqvia patient demographics include pediatric and adult patients. Pediatric patients are individuals who are under the age of 18 and require specialized care for growth and development. It is distributed through various channels, including hospitals, specialty pharmacies, home healthcare providers, and retail pharmacies, and is applied for primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy, and other indications.

Hyqvia Market Size and growth rate 2025 to 2029: Graph

What Is The Hyqvia Market Size 2025 And Growth Rate?

The hyqvia market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing global healthcare expenditure, growing awareness about autoimmune disorders, rising use of combination therapies, increasing investment in biotechnology, and growth in the prevalence of autoimmune diseases.

What Is The Hyqvia Market Growth Forecast?

The hyqvia market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing global healthcare expenditure, growing awareness about autoimmune disorders, rising use of combination therapies, increasing investment in biotechnology, and growth in the prevalence of autoimmune diseases. Major trends in the forecast period include technological advancements, personalized medicine, digital health solutions, genetic therapies, and the integration of artificial intelligence.

Book your 30 minutes free consultation with our research experts

How Is The Hyqvia Market Segmented?

The hyqvia market covered in this report is segmented –

1) By Patient Demographics: Pediatric Patients, Adult Patients

2) By Distribution Channel: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Retail Pharmacies

3) By Application: Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Other Applications

What Is Driving The Hyqvia Market? Impact Of Rising Autoimmune Diseases On The Growth Of The Hyqvia Market

The growing prevalence of autoimmune diseases is expected to drive the growth of the hyqvia market going forward. Autoimmune diseases are conditions in which the immune system mistakenly attacks healthy cells, tissues, or organs, leading to inflammation and dysfunction. Autoimmune diseases are rising due to a combination of factors, including genetic predisposition, environmental triggers, changes in diet, increased exposure to pollutants, and improved diagnostic capabilities. Hyqvia is used for autoimmune diseases as it delivers immunoglobulin therapy, which helps modulate the immune system and minimize abnormal immune responses that target the body’s own tissues. For instance, in August 2022, according to the National Library of Medicine, a US-based medical library, a systematic review of 464 studies identified 928 cases of autoimmune conditions associated with COVID-19 vaccination in 2022. Of these, 81.5% (756 cases) were new-onset autoimmune diseases, with symptoms usually emerging eight days post-vaccination. Most affected individuals were women (53.6%), with a median age of 48 years. Therefore, the growing prevalence of autoimmune diseases is driving the growth of the hyqvia market.

What Is Driving The Hyqvia Market? Rising Healthcare Investment Driving Growth In The HYQVIA Market

The increasing healthcare investment is expected to propel the growth of the hyqvia market going forward. Healthcare investment refers to the allocation of financial resources into healthcare-related businesses, technologies, research, and infrastructure to improve patient outcomes, support innovation, and drive industry growth. Healthcare investment is rising due to increasing demand for advanced medical treatments, technological innovations, an aging population, and a focus on improving global healthcare access and outcomes. Healthcare investment positively impacts HYQVIA by supporting its continued development, regulatory approvals, and broader access, ultimately driving adoption for treating immunodeficiency and CIDP. For instance, in December 2023, according to the U.S. Centers for Medicare & Medicaid Services, a US-based federal agency, U.S. healthcare spending grew by 4.1% in 2022, reaching $4.5 trillion, surpassing the 3.2% growth rate observed in 2021. The total amount spent on hospital care services rose 2.2% to $1.4 trillion. The amount spent on clinical and physician services increased by 2.7% to $884.9 billion. Therefore, the increasing healthcare investment is driving the hyqvia market.

Who Are The Major Players In The Global Hyqvia Market?

Major companies operating in the hyqvia market include Takeda Pharmaceutical Company Limited

What Are The Key Trends Of The Global Hyqvia Market? FDA Approval For Immune Globulin Infusion As Maintenance Therapy For CIDP

The ket trend in the hyqvia market is focusing on developing innovative products, such as immune globulin infusion, to treat chronic inflammatory demyelinating polyneuropathy (CIDP) and primary immunodeficiency (PI). Immune globulin infusion is a treatment that involves administering antibody-rich plasma proteins to address immune deficiencies and autoimmune disorders. For instance, in January 2024, Takeda Pharmaceutical Company Ltd., a Japan-based pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved its product, HYQVIA® (immune globulin infusion 10% [human] with recombinant human hyaluronidase), for use as a maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). The FDA approval permits HYQVIA to be used to prevent relapses of neuromuscular disability and impairment caused by CIDP, a rare neuromuscular disorder that affects approximately five to seven individuals per 100,000 in the U.S.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Hyqvia Market

North America was the largest region in the hyqvia market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the hyqvia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hyqvia market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada

What Defines the Hyqvia Market?

The hyqvia market consists of sales of hematology medications, gastrointestinal medications, vaccines, and biosimilars. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hyqvia Industry?

The hyqvia market research report is one of a series of new reports from The Business Research Company that provides hyqvia market statistics, including hyqvia industry global market size, regional shares, competitors with a hyqvia market share, detailed hyqvia market segments, market trends and opportunities, and any further data you may need to thrive in the hyqvia industry. This hyqvia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Hyqvia Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included !
Revenue Forecast In 2034	Included !
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Patient Demographics: Pediatric Patients, Adult Patients 2) By Distribution Channel: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Retail Pharmacies 3) By Application: Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Other Applications
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Takeda Pharmaceutical Company Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Hyqvia Market Characteristics

3. Hyqvia Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Hyqvia Market Trends And Strategies

5. Hyqvia Market -Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Hyqvia Growth Analysis And Strategic Analysis Framework

6.1. Global Hyqvia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Hyqvia Market Growth Rate Analysis

6.4. Global Hyqvia Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Hyqvia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Hyqvia Total Addressable Market (TAM)

7. Global Hyqvia Pricing Analysis & Forecasts

8. Hyqvia Market Segmentation

8.1. Global Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Pediatric Patients

Adult Patients

8.2. Global Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospitals

Specialty Pharmacies

Home Healthcare Providers

Retail Pharmacies

8.3. Global Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Primary Immunodeficiency

Chronic Inflammatory Demyelinating Polyneuropathy

Other Applications

9. Global Hyqvia Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Hyqvia Market Regional And Country Analysis

10.1. Global Hyqvia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Hyqvia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Hyqvia Market

11.1. Asia-Pacific Hyqvia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Hyqvia Market

12.1. China Hyqvia Market Overview

12.2. China Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Hyqvia Market

13.1. India Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Hyqvia Market

14.1. Japan Hyqvia Market Overview

14.2. Japan Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Hyqvia Market

15.1. Australia Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Hyqvia Market

16.1. South Korea Hyqvia Market Overview

16.2. South Korea Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Hyqvia Market

17.1. Western Europe Hyqvia Market Overview

17.2. Western Europe Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Hyqvia Market

18.1. UK Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Hyqvia Market

19.1. Germany Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Hyqvia Market

20.1. France Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Hyqvia Market

21.1. Eastern Europe Hyqvia Market Overview

21.2. Eastern Europe Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Hyqvia Market

22.1. North America Hyqvia Market Overview

22.2. North America Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Hyqvia Market

23.1. USA Hyqvia Market Overview

23.2. USA Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Hyqvia Market

24.1. Canada Hyqvia Market Overview

24.2. Canada Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Hyqvia Market

25.1. South America Hyqvia Market Overview

25.2. South America Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Hyqvia Market

26.1. Middle East Hyqvia Market Overview

26.2. Middle East Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Hyqvia Market

27.1. Africa Hyqvia Market Overview

27.2. Africa Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Hyqvia Market Competitive Landscape And Company Profiles

28.1. Hyqvia Market Competitive Landscape

28.2. Hyqvia Market Company Profiles

28.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

29. Global Hyqvia Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Hyqvia Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Hyqvia Market

32. Recent Developments In The Hyqvia Market

33. Hyqvia Market High Potential Countries, Segments and Strategies

33.1 Hyqvia Market In 2029 - Countries Offering Most New Opportunities

33.2 Hyqvia Market In 2029 - Segments Offering Most New Opportunities

33.3 Hyqvia Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Hyqvia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Hyqvia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Takeda Pharmaceutical Company Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Hyqvia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Hyqvia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Hyqvia Market, Segmentation By Patient Demographics, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Hyqvia Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Hyqvia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Takeda Pharmaceutical Company Limited Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

CAR-T Therapy Market 2021 - By Target Antigen (CD19, CD22, BCMA), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma), And By ...

Pharmaceutical Drugs Market 2024 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorde...

Oncology Drugs Market 2023 – By Type (Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Ca...

Dry Eye Medication Market 2021 - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous And Evaporative) By Distribution Channel (Hospi...

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Dru...

Dermatology Drugs Global Market Report 2022 – By Type (Acne Drugs, Dermatitis, Psoriasis, Other Drugs for Dermatology Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By R...

Gastrointestinal Drugs Global Market Report 2022 – By Type (Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And Antinauseants, Antidiarrhoeals), By Distribution Channel (Hospital Pharmacies, Retai...

Frequently Asked Questions

What is the definition of the Hyqvia market?

How will the Hyqvia market drivers and restraints affect the market dynamics? What forces will shape the Hyqvia industry going forward?

The Hyqvia market major growth driver - Impact Of Rising Autoimmune Diseases On The Growth Of The Hyqvia Market. For further insights on the Hyqvia market, request a sample here

What is the forecast market size or the forecast market value of the Hyqvia market?

The Hyqvia market size has grown strongly in recent years. The hyqvia market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing global healthcare expenditure, growing awareness about autoimmune disorders, rising use of combination therapies, increasing investment in biotechnology, and growth in the prevalence of autoimmune diseases. The hyqvia market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing global healthcare expenditure, growing awareness about autoimmune disorders, rising use of combination therapies, increasing investment in biotechnology, and growth in the prevalence of autoimmune diseases. Major trends in the forecast period include technological advancements, personalized medicine, digital health solutions, genetic therapies, and the integration of artificial intelligence. For further insights on the Hyqvia market, request a sample here

How is the Hyqvia market segmented?

The hyqvia market covered in this report is segmented –
1) By Patient Demographics: Pediatric Patients, Adult Patients
2) By Distribution Channel: Hospitals, Specialty Pharmacies, Home Healthcare Providers, Retail Pharmacies
3) By Application: Primary Immunodeficiency, Chronic Inflammatory Demyelinating Polyneuropathy, Other Applications For further insights on the Hyqvia market, request a sample here

Which region has the largest share of the Hyqvia market? What are the other regions covered in the report?

Who are the major players in the Hyqvia market?

Major companies operating in the hyqvia market include Takeda Pharmaceutical Company Limited . For further insights on the Hyqvia market, request a sample here.

What are the key trends in the Hyqvia market?

Major trends in the Hyqvia market include FDA Approval For Immune Globulin Infusion As Maintenance Therapy For CIDP. For further insights on the Hyqvia market, request a sample here.